Acute Carbamazepine Intoxication
Abstract
:1. Introduction
2. Case Report
3. Results
4. Discussion
Author Contributions
Funding
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Missio, G.; Moreno, D.H.; Demetrio, F.N.; Soeiro-de-Souza, M.G.; Fernandes, F.D.S.; Barros, V.B.; Moreno, R.A. A randomized controlled trial comparing lithium plus valproic acid versus lithium plus carbamazepine in young patients with type 1 bipolar disorder: The LICAVAL study. Trials 2019, 20, 608–609. [Google Scholar] [CrossRef] [PubMed]
- Huband, N.; Ferriter, M.; Nathan, R.; Jones, H. Antiepileptics for aggression and associated impulsivity. Cochrane Database Syst. Rev. 2010, 2010, CD003499. [Google Scholar] [CrossRef] [PubMed]
- Bendtsen, L.; Zakrzewska, J.M.; Heinskou, T.B.; Hodaie, M.; Leal, P.R.L.; Nurmikko, T.; Obermann, M.; Cruccu, G.; Maarbjerg, S. Advances in diagnosis, classification, pathophysiology, and management of trigeminal neuralgia. Lancet Neurol. 2020, 19, 784–796. [Google Scholar] [CrossRef]
- Brodie, M.J. Sodium Channel Blockers in the Treatment of Epilepsy. CNS Drugs 2017, 31, 527–534. [Google Scholar] [CrossRef] [PubMed]
- Davies, J.A. Mechanisms of action of antiepileptic drugs. Seizure 1995, 4, 267–271. [Google Scholar] [CrossRef] [Green Version]
- Spiller, H.A. Management of carbamazepine overdose. Pediatr. Emerg. Care 2001, 17, 452–456. [Google Scholar] [CrossRef] [PubMed]
- Bertilsson, L.; Bertilsson, L.; Tomson, T. Clinical Pharmacokinetics and Pharmacological Effects of Carbamazepine and Carbamazepine-10,11-Epoxide. Clin. Pharmacokinet. 1986, 11, 177–198. [Google Scholar] [CrossRef] [PubMed]
- Nogué Xarau, S. Chapter 67. Tóxicos Específicos. In Toxicología Clínica; Elsevier: Barcelona, Spain, 2019. [Google Scholar]
- Hirsch, A.; Wanounou, M.; Perlman, A.; Hirsh-Raccah, B.; Muszkat, M. The effect of multidrug exposure on neurological manifestations in carbamazepine intoxication: A nested case-control study. BMC Pharmacol. Toxicol. 2020, 21, 47. [Google Scholar] [CrossRef] [PubMed]
- Seymour, J.F. Carbamazepine Overdose. Features of 33 cases. Drug Saf. 1993, 8, 81–88. [Google Scholar] [CrossRef] [PubMed]
- Edlow, J.A.; Rabinstein, A.; Traub, S.J.; Wijdicks, E.F.M. Diagnosis of reversible causes of coma. Lancet 2014, 384, 2064–2076. [Google Scholar] [CrossRef]
- Dodds, T.J. Prescribed Benzodiazepines and Suicide Risk: A Review of the Literature. Prim. Care Companion CNS Disord. 2017, 19. [Google Scholar] [CrossRef] [PubMed]
- Yuodelis-Flores, C.; Ries, R.K. Addiction and suicide: A review. Am. J. Addict. 2015, 24, 98–104. [Google Scholar] [CrossRef] [PubMed]
- Hsu, W.-Y.; Chang, T.-G.; Chang, C.-C.; Chiu, N.-Y.; Lin, C.-H.; Lane, H.-Y. Suicide Ideation among Outpatients with Alcohol Use Disorder. Behav. Neurol. 2022, 2022, 4138629. [Google Scholar] [CrossRef] [PubMed]
- Brahmi, N.; Kouraichi, N.; Thabet, H.; Amamou, M. Influence of activated charcoal on the pharmacokinetics and the clinical features of carbamazepine poisoning. Am. J. Emerg. Med. 2006, 24, 440–443. [Google Scholar] [CrossRef] [PubMed]
- Baylis, S.; Costa-Pinto, R.; Hodgson, S.; Bellomo, R.; Baldwin, I. Combined Hemoperfusion and Continuous Veno-Venous Hemofiltration for Carbamazepine Intoxication. Blood Purif. 2021, 1–5. [Google Scholar] [CrossRef] [PubMed]
- Kasarskis, E.J.; Kuo, C.S.; Berger, R.; Nelson, K.R. Carbamazepine-induced cardiac dysfunction. Characterization of two distinct clinical syndromes. Arch. Intern. Med. 1992, 152, 186–191. [Google Scholar] [CrossRef]
- Harika, V.; Parveen, S.; Venkatasubbaiah, M.; Varma, K.S.; Devasree, S. Carbamazepine-induced hyperglycemia: A rare case report. Indian J. Pharmacol. 2019, 51, 352–353. [Google Scholar] [CrossRef]
Plasma Concentration | Clinical Expression |
---|---|
4–12 mcg/mL | Therapeutic range |
12–16 mcg/mL | Ataxia, nystagmus |
16–24 mcg/mL | Obtundation, stupor |
24–40 mcg/mL | Alternating between reactive coma, agitation, hallucinations, choreographic movements |
40–60 mcg/mL | Reactive coma, mydriasis, risk of seizures, decerebrate movements |
>60 mcg/mL | Unreactive coma, hypoventilation, cardiotoxicity, possible status epilepticus. |
Cause | Type |
---|---|
Stroke | Ischemic, hemorrhagic |
Seizure | Including non-convulsive status epilepticus |
Drug overdose/toxins | Opioids, CO, antipsychotics, antidepressants, antiepileptic drugs… |
Metabolic | Hypoglycaemia, hyponatraemia, hypercalcaemia, hyperammonaemia, hepatic encephalopathy… |
Infection | Including central nervous system infections |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Gallego, M.D.C.; García, M.A. Acute Carbamazepine Intoxication. Neurol. Int. 2022, 14, 614-618. https://doi.org/10.3390/neurolint14030049
Gallego MDC, García MA. Acute Carbamazepine Intoxication. Neurology International. 2022; 14(3):614-618. https://doi.org/10.3390/neurolint14030049
Chicago/Turabian StyleGallego, María Dolores Calabria, and Mónica Alañá García. 2022. "Acute Carbamazepine Intoxication" Neurology International 14, no. 3: 614-618. https://doi.org/10.3390/neurolint14030049
APA StyleGallego, M. D. C., & García, M. A. (2022). Acute Carbamazepine Intoxication. Neurology International, 14(3), 614-618. https://doi.org/10.3390/neurolint14030049